• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aerie Pharmaceuticals Inc

+ Add to Watchlist

AERI:US

30.7600 USD 0.6600 2.19%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Aerie Pharmaceuticals Inc (AERI)

Open: 30.0100 Day's Range: 29.8400 - 31.0800 Volume: 826,008
Previous Close: 30.1000 52wk Range: 13.6600 - 32.5000 1-Yr Rtn: +87.68%

Stock Chart for AERI

No chart data available.
  • AERI:US 30.7600
  • 1D
  • 1M
  • 1Y
30.1000
Interactive AERI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AERI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7665
Est. EPS (USD) (12/2014) -1.4350
Est. PEG Ratio -
Market Cap (M USD) 737.76
Shares Outstanding (M) 23.98
30 Day Average Volume 321,244
Price/Book (mrq) 17.4873
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AERI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AERI

Aerie Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The Company discovers, develops, and distributes pharmaceutical products for the treatment of glaucoma and other diseases of the eye. Aerie Pharmaceuticals serves customers worldwide.

Vicente Anido JrChairman/CEOThomas A MitroPresident/COO
Richard J Rubino "Rich"CFO/SecretaryBrian LevyChief Medical Officer
More Company Profile & Key Executives for AERI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil